Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System Read more about Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus Read more about Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48% Read more about Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance Read more about Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024 Read more about Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds Read more about Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million Read more about Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024 Read more about Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial Read more about Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference Read more about Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference